{"id":55816,"date":"2023-04-13T23:07:17","date_gmt":"2023-04-13T21:07:17","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/aptar-issues-financial-information-recast-for-previously-announced-strategic-realignment-of-two-of-its-business-reporting-segments\/"},"modified":"2023-04-13T23:07:17","modified_gmt":"2023-04-13T21:07:17","slug":"aptar-issues-financial-information-recast-for-previously-announced-strategic-realignment-of-two-of-its-business-reporting-segments","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/aptar-issues-financial-information-recast-for-previously-announced-strategic-realignment-of-two-of-its-business-reporting-segments\/","title":{"rendered":"Aptar Issues Financial Information Recast for Previously Announced Strategic Realignment of Two of its Business Reporting Segments"},"content":{"rendered":"
\n

CRYSTAL LAKE, Ill.–(BUSINESS WIRE)–AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, has issued financial information recast for the previously announced strategic segment realignment<\/a> of two of its business reporting segments.<\/p>\n

<\/a><\/p>\n

\nThe financial information reflects the past two years of recast performance for Aptar\u2019s two realigned reporting segments, Aptar Closures and Aptar Beauty. Aptar Pharma\u2019s financial statements are unchanged.<\/p>\n

\nThe recast financial information can be found in the company\u2019s April 13, 2023 Form 8-K<\/a>.<\/p>\n

\nAbout Aptar<\/b><\/p>\n

\nAptar is a global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing and active material science solutions and services. Aptar\u2019s innovative solutions and services serve a variety of end markets including pharmaceutical, beauty, food, beverage, personal care and home care. Using insights, proprietary design, engineering and science to create dispensing, dosing and protective technologies for many of the world\u2019s leading brands, Aptar in turn makes a meaningful difference in the lives, looks, health and homes of millions of patients and consumers around the world. Aptar is headquartered in Crystal Lake, Illinois and has 13,500 dedicated employees in 20 countries. For more information, visit www.aptar.com<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Relations Contact<\/span>:<\/b>
Mary Skafidas
\n
mary.skafidas@aptar.com<\/a>
+1 347-351-6407<\/p>\n

\nMedia Contact:<\/span><\/b>
Katie Reardon
\n
katie.reardon@aptar.com<\/a>
+1 815-479-5671<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

CRYSTAL LAKE, Ill.–(BUSINESS WIRE)–AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, has issued financial information recast for the previously announced strategic segment realignment of two of its business reporting segments. The financial information reflects the past two years of recast performance for Aptar\u2019s … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55816","6":"format-standard","7":"category-industry"},"yoast_head":"\nAptar Issues Financial Information Recast for Previously Announced Strategic Realignment of Two of its Business Reporting Segments - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/aptar-issues-financial-information-recast-for-previously-announced-strategic-realignment-of-two-of-its-business-reporting-segments\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aptar Issues Financial Information Recast for Previously Announced Strategic Realignment of Two of its Business Reporting Segments - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CRYSTAL LAKE, Ill.–(BUSINESS WIRE)–AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, has issued financial information recast for the previously announced strategic segment realignment of two of its business reporting segments. The financial information reflects the past two years of recast performance for Aptar\u2019s ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/aptar-issues-financial-information-recast-for-previously-announced-strategic-realignment-of-two-of-its-business-reporting-segments\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-13T21:07:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230413005647\/en\/685330\/21\/aptar_logo_rgb.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aptar-issues-financial-information-recast-for-previously-announced-strategic-realignment-of-two-of-its-business-reporting-segments\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aptar-issues-financial-information-recast-for-previously-announced-strategic-realignment-of-two-of-its-business-reporting-segments\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Aptar Issues Financial Information Recast for Previously Announced Strategic Realignment of Two of its Business Reporting Segments\",\"datePublished\":\"2023-04-13T21:07:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aptar-issues-financial-information-recast-for-previously-announced-strategic-realignment-of-two-of-its-business-reporting-segments\\\/\"},\"wordCount\":244,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aptar-issues-financial-information-recast-for-previously-announced-strategic-realignment-of-two-of-its-business-reporting-segments\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230413005647\\\/en\\\/685330\\\/21\\\/aptar_logo_rgb.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aptar-issues-financial-information-recast-for-previously-announced-strategic-realignment-of-two-of-its-business-reporting-segments\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aptar-issues-financial-information-recast-for-previously-announced-strategic-realignment-of-two-of-its-business-reporting-segments\\\/\",\"name\":\"Aptar Issues Financial Information Recast for Previously Announced Strategic Realignment of Two of its Business Reporting Segments - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aptar-issues-financial-information-recast-for-previously-announced-strategic-realignment-of-two-of-its-business-reporting-segments\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aptar-issues-financial-information-recast-for-previously-announced-strategic-realignment-of-two-of-its-business-reporting-segments\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230413005647\\\/en\\\/685330\\\/21\\\/aptar_logo_rgb.jpg\",\"datePublished\":\"2023-04-13T21:07:17+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aptar-issues-financial-information-recast-for-previously-announced-strategic-realignment-of-two-of-its-business-reporting-segments\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aptar-issues-financial-information-recast-for-previously-announced-strategic-realignment-of-two-of-its-business-reporting-segments\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aptar-issues-financial-information-recast-for-previously-announced-strategic-realignment-of-two-of-its-business-reporting-segments\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230413005647\\\/en\\\/685330\\\/21\\\/aptar_logo_rgb.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230413005647\\\/en\\\/685330\\\/21\\\/aptar_logo_rgb.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aptar-issues-financial-information-recast-for-previously-announced-strategic-realignment-of-two-of-its-business-reporting-segments\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aptar Issues Financial Information Recast for Previously Announced Strategic Realignment of Two of its Business Reporting Segments\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aptar Issues Financial Information Recast for Previously Announced Strategic Realignment of Two of its Business Reporting Segments - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/aptar-issues-financial-information-recast-for-previously-announced-strategic-realignment-of-two-of-its-business-reporting-segments\/","og_locale":"en_US","og_type":"article","og_title":"Aptar Issues Financial Information Recast for Previously Announced Strategic Realignment of Two of its Business Reporting Segments - Pharma Trend","og_description":"CRYSTAL LAKE, Ill.–(BUSINESS WIRE)–AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions and services, has issued financial information recast for the previously announced strategic segment realignment of two of its business reporting segments. The financial information reflects the past two years of recast performance for Aptar\u2019s ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/aptar-issues-financial-information-recast-for-previously-announced-strategic-realignment-of-two-of-its-business-reporting-segments\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-13T21:07:17+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230413005647\/en\/685330\/21\/aptar_logo_rgb.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/aptar-issues-financial-information-recast-for-previously-announced-strategic-realignment-of-two-of-its-business-reporting-segments\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/aptar-issues-financial-information-recast-for-previously-announced-strategic-realignment-of-two-of-its-business-reporting-segments\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Aptar Issues Financial Information Recast for Previously Announced Strategic Realignment of Two of its Business Reporting Segments","datePublished":"2023-04-13T21:07:17+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/aptar-issues-financial-information-recast-for-previously-announced-strategic-realignment-of-two-of-its-business-reporting-segments\/"},"wordCount":244,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/aptar-issues-financial-information-recast-for-previously-announced-strategic-realignment-of-two-of-its-business-reporting-segments\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230413005647\/en\/685330\/21\/aptar_logo_rgb.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/aptar-issues-financial-information-recast-for-previously-announced-strategic-realignment-of-two-of-its-business-reporting-segments\/","url":"https:\/\/pharma-trend.com\/en\/aptar-issues-financial-information-recast-for-previously-announced-strategic-realignment-of-two-of-its-business-reporting-segments\/","name":"Aptar Issues Financial Information Recast for Previously Announced Strategic Realignment of Two of its Business Reporting Segments - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/aptar-issues-financial-information-recast-for-previously-announced-strategic-realignment-of-two-of-its-business-reporting-segments\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/aptar-issues-financial-information-recast-for-previously-announced-strategic-realignment-of-two-of-its-business-reporting-segments\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230413005647\/en\/685330\/21\/aptar_logo_rgb.jpg","datePublished":"2023-04-13T21:07:17+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/aptar-issues-financial-information-recast-for-previously-announced-strategic-realignment-of-two-of-its-business-reporting-segments\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/aptar-issues-financial-information-recast-for-previously-announced-strategic-realignment-of-two-of-its-business-reporting-segments\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/aptar-issues-financial-information-recast-for-previously-announced-strategic-realignment-of-two-of-its-business-reporting-segments\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230413005647\/en\/685330\/21\/aptar_logo_rgb.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230413005647\/en\/685330\/21\/aptar_logo_rgb.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/aptar-issues-financial-information-recast-for-previously-announced-strategic-realignment-of-two-of-its-business-reporting-segments\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Aptar Issues Financial Information Recast for Previously Announced Strategic Realignment of Two of its Business Reporting Segments"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55816","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55816"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55816\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55816"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55816"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55816"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}